BC Extra | Oct 1, 2019
Company News

ElevateBio launches HighPassBio with TCR immunotherapy focus

Less than five months after its launch, ElevateBio has announced a second portfolio company: HighPassBio, which is developing T cell immunotherapies based on research from the Fred Hutchinson Cancer Research Center. HighPassBio’s lead candidate is...
BC Week In Review | Mar 2, 2018
Clinical News

University of Birmingham reports Phase I data for leukemia vaccine

Researchers at the University of Birmingham (Birmingham, U.K.) reported data from a Phase I trial in 9 healthy volunteers showing that escalating doses of leukemia candidate pDOM-HA-1 boosted with a modified vaccinia Ankara virus (MVA)...
BioCentury | Dec 9, 2017
Product Development

Multimodal meeting

This year’s clinical abstracts at the American Society of Hematology meeting hint at how newer treatment modalities -- cell therapies in cancer and gene therapies in hematology -- will branch out into new indications and...
Items per page:
1 - 3 of 3